Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Mar;68(3):313-6.
doi: 10.1136/jnnp.68.3.313.

Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

Affiliations

Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

B J Snow et al. J Neurol Neurosurg Psychiatry. 2000 Mar.

Abstract

Objectives: To examine the distribution of striatal dopaminergic function in humans with parkinsonism induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) to determine if there is a caudate-putamen gradient as is seen in idiopathic Parkinson's disease.

Methods: We scanned nine humans exposed to MPTP with parkinsonism ranging from minimal to severe using [(18)F]fluorodopa (FD) and high resolution PET. The results were compared with those of 10 patients with Parkinson's disease and six normal subjects.

Results: In the MPTP group there was an equal degree of reduction of dopaminergic function in the caudate and putamen. This was different from the greater putaminal than caudate loss in Parkinson's disease (p<0.001).

Conclusions: Parkinson's disease is not caused by transient exposure to MPTP.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Neurology. 1967 May;17(5):427-42 - PubMed
    1. J Neurol Sci. 1979 Sep;43(1):59-82 - PubMed
    1. Science. 1983 Feb 25;219(4587):979-80 - PubMed
    1. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4546-50 - PubMed
    1. Can J Neurol Sci. 1984 Feb;11(1 Suppl):174-9 - PubMed

Publication types

Substances